A Clinic-wide Intervention (Primary Care-GI Connect) for Improving Rates of Colonoscopy After Abnormal Fecal Immunochemical Test Result in Patients at Federally Qualified Health Centers

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
AgeNot listed
SponsorJonsson Comprehensive Cancer Center

About this trial

This clinical trial evaluates a clinic-wide intervention called Primary Care-Gastrointestinal (GI) Connect for improving follow-up colonoscopy rates in patients at a Federally Qualified Health Center (FQHC) who have an abnormal fecal immunochemical test (FIT) result. Colorectal cancer screening reduces colorectal cancer incidence and mortality but is underutilized.The most accessible, feasible, and common colorectal cancer screening modality for average-risk individuals in low resource settings such as FQHCs is the stool-based FIT. However, the benefit of FIT screening on colorectal cancer risk is realized only if individuals with abnormal FIT results undergo timely follow-up colonoscopy. Follow-up colonoscopy rates are low and there are many barriers to follow-up colonoscopy in safety net settings such as FQHCs. Effective interventions that are multi-component and improve care coordination are needed to improve abnormal FIT follow-up rates in FQHCs. The Primary Care-GI Connect intervention includes components that enhance care coordination, standardize the referral process, and engage both primary care and specialist physicians. This clinic-wide intervention may improve rates of follow-up colonoscopy after abnormal FIT results in patients seen at FQHCs.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

6 adult care NEVHC clinic sites

Disqualifiers

None

Trial design

Design model

Parallel

Treatments tested in this trial

  • Best Practice

    Other intervention

    Receive clinical care consistent with current practice

  • Communication Intervention

    Other intervention

    Receive standardized communication from FIT QI champion

  • Communication Intervention

    Other intervention

    Receive coordination from GI liaisons

  • Coordination

    Other intervention

    Receive enhanced GI care coordination

  • Educational Intervention

    Other intervention

    Watch pre-colonoscopy educational video

  • Electronic Health Record Review

    Other intervention

    Undergo FIT result review by Primary Care FIT Tracker

  • Electronic Health Record Review

    Other intervention

    Ancillary studies

  • Informational Intervention

    Other intervention

    Undergo generation and review of GI FIT Tracker report

  • Informational Intervention

    Other intervention

    Receive informational sheet

  • Interview

    Other intervention

    Ancillary studies

  • Patient Navigation

    Behavioral

    Receive navigation from GI liaisons

  • Referral

    Other intervention

    Receive referral

  • Referral

    Other intervention

    Receive referral per standardized template

  • Text Message-Based Navigation Intervention

    Other intervention

    Receive follow-up text message

Treatment groups

1,500 Participants
are divided into 2 treatment groups
Group A: Arm I (usual care)Active comparator 5 interventions
Group B: Arm II (Usual care + Primary Care - GI Connect)Experimental treatment 10 interventions

Trial outcomes

Primary outcomes

1

Follow-up colonoscopy rates

Evaluated in patients with an abnormal fecal immunochemical test (FIT) result using electronic health record data. Will use a difference-in-differences approach, assessing whether change in completion rates from baseline to the implementation period differs between the intervention and usual care conditions, thus accounting for potential differences among clinics pre-implementation. Will fit a mixed effects logistic regression model with a dependent variable of patient-level colonoscopy completion within 6 months (yes/no).

Time frame
At 6 months
2

Implementation quality: fit tracker

The Investigators will measure the percent of cases for which the FIT tracker is used, as well as its use for each step in the process. For these measures, we will also measure time to completion.

Time frame
Monthly intervals up to 3 years
3

Implementation quality: patient notification

The Investigators will measure both the percent of patients who are notified of their abnormal results as well as the time to notification.

Time frame
Monthly intervals up to 3 years
4

Implementation quality: patient referral

The Investigators will measure the percent of patients who receive a referral.

Time frame
Monthly intervals up to 3 years

Secondary outcomes

1

Time to colonoscopy

The Investigators will use a difference-in-differences approach, assessing whether change in completion rates from baseline to the implementation period differs between the intervention and usual care conditions, thus accounting for potential differences among clinics pre-implementation. Will fit a mixed effects logistic regression model with a dependent variable of patient-level colonoscopy completion.

Time frame
0-24 months
2

Follow-up colonoscopy rates

Evaluated in patients with an abnormal FIT result using electronic health record data. Will use a difference-in-differences approach, assessing whether change in completion rates from baseline to the implementation period differs between the intervention and usual care conditions, thus accounting for potential differences among clinics pre-implementation. Will fit a mixed effects logistic regression model with a dependent variable of patient-level colonoscopy completion within 9 months (yes/no).

Time frame
At 9 months and at 12 months
3

Factors associated with Implementation

The Investigators will use the Organizational Readiness to Implement Change tool to measure responses from clinic stakeholders at each site. This is a standardized tool.

Time frame
At pre-intervention (1-2 years) and at the implementation midpoint (3-4 years)
4

Reported challenges to implementation

In qualitative interviews with stakeholders and on standardized forms, we will learn about major challenges to implementation across clinics and over time. These will be qualitative data.

Time frame
Up to 3 years

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Jonsson Comprehensive Cancer Center

Lead sponsor

National Cancer Institute (NCI)

Collaborator